Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 96

Similar articles for PubMed (Select 23170979)

1.

Novel cancerization marker, TP53, and its role in distinguishing normal tissue adjacent to cancerous tissue from normal tissue adjacent to benign tissue.

Liu GY, Liu KH, Li Y, Pan C, Su JQ, Liao HF, Yv RX, Li ZH, Yuan L, Zhang HJ, Tzeng CM, Xiong B.

World J Surg Oncol. 2012 Nov 21;10:252. doi: 10.1186/1477-7819-10-252.

4.

Incidence of chromosomes 1 and 17 aneusomy in breast cancer and adjacent tissue: an interphase cytogenetic study.

Botti C, Pescatore B, Mottolese M, Sciarretta F, Greco C, Di Filippo F, Gandolfo GM, Cavaliere F, Bovani R, Varanese A, Cianciulli AM.

J Am Coll Surg. 2000 May;190(5):530-9.

PMID:
10801019
5.

Alterations of the p53 tumor suppressor gene in carcinoma in situ of the testis.

Kuczyk MA, Serth J, Bokemeyer C, Jonassen J, Machtens S, Werner M, Jonas U.

Cancer. 1996 Nov 1;78(9):1958-66.

PMID:
8909317
6.

Correlation of genetic and immunodetection of TP53 mutations in malignant and benign prostate tissues.

Wertz IE, Deitch AD, Gumerlock PH, Gandour-Edwards R, Chi SG, de Vere White RW.

Hum Pathol. 1996 Jun;27(6):573-80.

PMID:
8666367
7.

p16INK4a hypermethylation and p53, p16 and MDM2 protein expression in esophageal squamous cell carcinoma.

Taghavi N, Biramijamal F, Sotoudeh M, Khademi H, Malekzadeh R, Moaven O, Memar B, A'rabi A, Abbaszadegan MR.

BMC Cancer. 2010 Apr 13;10:138. doi: 10.1186/1471-2407-10-138.

8.

Tissue array for Tp53, C-myc, CCND1 gene over-expression in different tumors.

Liu GY, Luo Q, Xiong B, Pan C, Yin P, Liao HF, Zhuang WC, Gao HZ.

World J Gastroenterol. 2008 Dec 21;14(47):7199-207.

9.

Methylation profile of TP53 regulatory pathway and mtDNA alterations in breast cancer patients lacking TP53 mutations.

Barekati Z, Radpour R, Kohler C, Zhang B, Toniolo P, Lenner P, Lv Q, Zheng H, Zhong XY.

Hum Mol Genet. 2010 Aug 1;19(15):2936-46. doi: 10.1093/hmg/ddq199. Epub 2010 May 12.

10.

TP53 mutations and abnormal p53 protein staining in breast carcinomas related to prognosis.

Thorlacius S, Thorgilsson B, Björnsson J, Tryggvadottir L, Börresen AL, Ogmundsdottir HM, Eyfjörd JE.

Eur J Cancer. 1995 Oct;31A(11):1856-61.

PMID:
8541113
11.

Immunohistochemical analysis of p53 expression in anal squamous neoplasia.

Ogunbiyi OA, Scholefield JH, Smith JH, Polacarz SV, Rogers K, Sharp F.

J Clin Pathol. 1993 Jun;46(6):507-12.

12.

p53 as an independent prognostic marker in lymph node-negative breast cancer patients.

Silvestrini R, Benini E, Daidone MG, Veneroni S, Boracchi P, Cappelletti V, Di Fronzo G, Veronesi U.

J Natl Cancer Inst. 1993 Jun 16;85(12):965-70.

PMID:
8496982
13.

TP53 tumor-suppressor gene and human carcinogenesis.

Basset-Séguin N, Molès JP, Mils V, Dereure O, Guilhou JJ.

Exp Dermatol. 1993 Jun;2(3):99-105. Review.

PMID:
8162331
14.

Genetic alterations of the TP53 gene, p53 protein expression and HPV infection in primary cervical carcinomas.

Helland A, Holm R, Kristensen G, Kaern J, Karlsen F, Trope C, Nesland JM, Børresen AL.

J Pathol. 1993 Oct;171(2):105-14.

PMID:
8283348
15.

Correlation between different p53 expression patterns and chromosome 17 imbalances in pancreatic ductal adenocarcinoma based on tissue microarray analysis.

Tsiambas E, Kravvaritis C, Tsounis D, Salemis NS, Niotis A, Niotis TH, Rigopoulos DN, Karameris A, Athanasiou AE, Patsouris E, Karakitsos P.

J BUON. 2010 Jan-Mar;15(1):94-100.

PMID:
20414934
16.

A hybrid machine learning-based method for classifying the Cushing's Syndrome with comorbid adrenocortical lesions.

Yang JY, Yang MQ, Luo Z, Ma Y, Li J, Deng Y, Huang X.

BMC Genomics. 2008;9 Suppl 1:S23. doi: 10.1186/1471-2164-9-S1-S23.

17.

Genetic instabilities of chromosome 9, 17 and accumulation of p53 overexpression during multistage tumorigesis in head and neck cancer.

Charuruks N, Shin DM, Voravud N, Ro JY, Hong WK, Hittelman WN.

J Med Assoc Thai. 1996 Dec;79 Suppl 1:S104-12.

PMID:
9071074
18.

Prognostic significance of the tumor suppressor gene maspin in non-small cell lung cancer.

Hirai K, Koizumi K, Haraguchi S, Hirata T, Mikami I, Fukushima M, Yamagishi S, Kawashima T, Okada D, Shimizu K, Kawamoto M.

Ann Thorac Surg. 2005 Jan;79(1):248-53.

PMID:
15620951
19.

Tissue microarray analysis of cytoskeletal actin-associated biomarkers gelsolin and E-cadherin in urothelial carcinoma.

Rao J, Seligson D, Visapaa H, Horvath S, Eeva M, Michel K, Pantuck A, Belldegrun A, Palotie A.

Cancer. 2002 Sep 15;95(6):1247-57.

20.

Molecular genetic studies of tumor suppressor gene regions on chromosomes 13 and 17 in colorectal tumors.

Lothe RA, Fossli T, Danielsen HE, Stenwig AE, Nesland JM, Gallie B, Børresen AL.

J Natl Cancer Inst. 1992 Jul 15;84(14):1100-8.

PMID:
1619684
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk